1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Aligos Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME) ALG-000184, TDF - Chronic Hepatitis B Infection | Phase 2 | Active not recruiting | Aligos Therapeutics | 200 | 2025-07-15 | 2026-09-11 |
| ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) ALG-055009, Placebo - NASH, MASH | Phase 2 | Completed | Aligos Therapeutics | 102 | 2024-04-01 | 2025-02-17 |
Hepatitis B (1) · Hepatitis B, Chronic (1) · Liver Diseases (1) · Non-alcoholic Fatty Liver Disease (1)
United States (2) · Bulgaria (1) · Canada (1) · China (1) · France (1) · Hong Kong (1) · Italy (1) · Moldova (1) · New Zealand (1) · Romania (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1)